BEUDAMED
    6 results · 8ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters FDA Pre Market Approval × Classification: FDA Class 2 × Clear all

    Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)

    FDA Pre-Market Approval
    FDA Class 2 ·CA 125 ANTIBODY RIA

    Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)

    FDA Pre-Market Approval
    FDA Class 2 ·CA 125 ANTIBODY RIA

    Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)

    FDA Pre-Market Approval
    FDA Class 2 ·CA 125 ANTIBODY RIA

    Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)

    FDA Pre-Market Approval
    FDA Class 2 ·CA 125 ANTIBODY RIA

    Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)

    FDA Pre-Market Approval
    FDA Class 2 ·CA 125 ANTIBODY RIA

    Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125)

    FDA Pre-Market Approval
    FDA Class 2 ·CA 125 ANTIBODY RIA